Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $1.0 billion.

  • GoHealth's Liabilities and Shareholders Equity fell 2316.42% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 511.59%. This contributed to the annual value of $1.5 billion for FY2024, which is 74.33% down from last year.
  • GoHealth's Liabilities and Shareholders Equity amounted to $1.0 billion in Q3 2025, which was down 2316.42% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, GoHealth's Liabilities and Shareholders Equity peaked at $2.1 billion during Q3 2021, and registered a low of $1.0 billion during Q3 2025.
  • Over the past 5 years, GoHealth's median Liabilities and Shareholders Equity value was $1.5 billion (recorded in 2023), while the average stood at $1.6 billion.
  • As far as peak fluctuations go, GoHealth's Liabilities and Shareholders Equity soared by 21116339990000.0% in 2021, and later crashed by 2818.97% in 2023.
  • Over the past 5 years, GoHealth's Liabilities and Shareholders Equity (Quarter) stood at $2.1 billion in 2021, then dropped by 19.8% to $1.7 billion in 2022, then decreased by 9.63% to $1.5 billion in 2023, then decreased by 0.74% to $1.5 billion in 2024, then tumbled by 30.77% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.4 billion during Q1 2025.